pKLV2-U6gRNA5(FAM58A_v3_6-5)-PGKpuroBFP-W
(Plasmid
#246516)
-
PurposeLentiviral vector expressing gFAM58A_v3_6-5
-
Depositing Lab
-
Depositing OrganizationKyoto University, Institute for Life and Medical Sciences
Located in Japan -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 246516 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepKLV2-U6gRNA5(BbsI)-PGKpuroGFP-W
-
Backbone manufacturerKosuke Yusa
- Backbone size w/o insert (bp) 8631
- Total vector size (bp) 8650
-
Vector typeMammalian Expression, Lentiviral, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namegFAM58A_v3_6-5
-
gRNA/shRNA sequenceCTCCGCAGGTGTCAAGCTA
-
SpeciesH. sapiens (human)
- Promoter Human U6 promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BbsI (destroyed during cloning)
- 3′ cloning site BbsI (destroyed during cloning)
- 5′ sequencing primer AGATAATTAGAATTAATTTGACTG
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pKLV2-U6gRNA5(FAM58A_v3_6-5)-PGKpuroBFP-W was a gift from Kosuke Yusa (Addgene plasmid # 246516 ; http://n2t.net/addgene:246516 ; RRID:Addgene_246516) -
For your References section:
CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition. Islam S, Tarumoto Y, Takano M, Sugino S, Nishibuchi G, Mizutani A, Yamakawa H, Morishita D, Yusa K. Cell Death Dis. 2026 Jun 11;17(1):737. doi: 10.1038/s41419-026-08973-x. 10.1038/s41419-026-08973-x PubMed 42270604